Jim Wassil, CHIEF OPERATING OFFICER at Vaxcyte, Inc. (PCVX), sold 15,760 shares at $108.25 ($1.7M) on 2024-11-01, disclosed to the SEC on 2024-11-04.
Scheduled sale ($1.7M) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $106.34 | 4,955 | $527K | 31.3% |
| 2 | $106.34 | 4,955 | $527K | 31.3% |
| 3 | $107.20 | 2,174 | $233K | 13.9% |
| 4 | $107.20 | 2,174 | $233K | 13.9% |
| 5 | $108.25 | 631 | $68K | 4.1% |
| 6 | $108.25 | 631 |
| $68K |
| 4.1% |
| 7 | $108.93 | 240 | $26K | 1.6% |
| Total | $106.77 avg | 15,760 | $1.7M | 100% |
| Filing → |
| PCVX | SELL | 2026-09-02 | $212K | — | Filing → |
| PCVX | SELL | 2026-08-05 | $121K | — | Filing → |
| PCVX | SELL | 2026-07-06 | $127K | — | Filing → |